F.Biotechnology Dis.Fd.A USD
LU0109394709
F.Biotechnology Dis.Fd.A USD/ LU0109394709 /
| NAV2024-04-18 |
Chg.-0.6200 |
Type of yield |
Investment Focus |
Investment company |
| 38.6800USD |
-1.58% |
reinvestment |
Equity
Worldwide
|
Franklin Templeton ▶ |
Investment goal
The Fund aims to capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
Master data
| Type of yield: |
reinvestment |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Biotechnology |
| Benchmark: |
NASDAQ Biotechnology Index |
| Business year start: |
07-01 |
| Last Distribution: |
- |
| Depository bank: |
J.P. Morgan SE, Niederlassung Luxemburg |
| Fund domicile: |
Luxembourg |
| Distribution permission: |
Austria, Germany, Switzerland, United Kingdom |
| Fund manager: |
Evan McCulloch, Wendy Lam, Akiva Felt |
| Fund volume: |
1.85 bill.
USD
|
| Launch date: |
2000-04-03 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
5.75% |
| Max. Administration Fee: |
1.50% |
| Minimum investment: |
1,000.00 USD |
| Deposit fees: |
0.14% |
| Redemption charge: |
0.00% |
| Key Investor Information: |
Download (Print version) |
Investment company
| Funds company: |
Franklin Templeton |
| Address: |
Schottenring 16, 2.OG, 1010, Wien |
| Country: |
Austria |
| Internet: |
www.franklintempleton.at
|
Assets
| Stocks |
|
93.71% |
| Others |
|
6.29% |
Countries
| United States of America |
|
76.06% |
| Netherlands |
|
4.35% |
| Denmark |
|
4.21% |
| United Kingdom |
|
3.48% |
| Ireland |
|
2.66% |
| France |
|
1.05% |
| Cayman Islands |
|
0.60% |
| Canada |
|
0.48% |
| Germany |
|
0.44% |
| Bermuda |
|
0.40% |
| Others |
|
6.27% |
Branches
| Pharma/Biotechnology |
|
88.40% |
| Healthcare services |
|
4.87% |
| Healthcare appliances |
|
0.44% |
| Others |
|
6.29% |
